|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 323 USD | +1.28% |
|
+2.42% | +19.32% |
| 07-12 | Bernstein Adjusts Price Target on HCA Healthcare to $362 From $317 | MT |
| 07-09 | Barclays Adjusts HCA Healthcare's Price Target to $376 From $367, Keeps Overweight Rating | MT |
HCA Healthcare, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was USD 58,752 million compared to USD 51,533 million a year ago. Net income was USD 6,956 million compared to USD 3,754 million a year ago.
Diluted earnings per share from continuing operations was USD 21.16 compared to USD 10.93 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +19.32% | 84.59B | |
| -21.99% | 77.33B | |
| +0.92% | 27.12B | |
| -5.06% | 18.19B | |
| +7.91% | 18.49B | |
| +7.69% | 16.49B | |
| +76.20% | 13.55B | |
| +76.56% | 13.03B | |
| -27.72% | 12.43B | |
| +20.55% | 12.3B |
HCA HEALTHCARE, INC. 
